Status:

WITHDRAWN

TREAT Foot Drop After Stroke With Ankle Robot

Lead Sponsor:

NextStep Robotics Inc.

Collaborating Sponsors:

University of Maryland, Baltimore

Conditions:

Foot Drop

Stroke

Eligibility:

All Genders

21-75 years

Phase:

NA

Brief Summary

Researchers at the University of Maryland Rehabilitation and Orthopaedic Institute are looking for individuals who have suffered a stroke and have leg and ankle weakness (foot-drop), to participate in...

Detailed Description

This study is designed to see if the ankle robot is safe and effective to use in restoring gait function in individuals with foot drop. This research project will be conducted at the University of Ma...

Eligibility Criteria

Inclusion

  • Age 21-75 years
  • Greater than 3 months post stroke
  • Hemiparetic stroke with foot drop (Dorsiflexion deficit)
  • Dorsiflexion deficit for active range of motion (unable to reach zero degrees)
  • Dorsiflexion deficit for strength with a manual motor score between 1/5 and 4/5
  • Mild-moderate severity hemiparetic gait, identified by reduced stance, or reduced stance plus increased swing on affected side
  • Able to participate in physical therapy for mobility recovery, defined by capacity to walk 10-m over-ground, albeit with minimal assist (FIM Mobility Subscale 4; subject can perform 75% of the task), supervision (FIM Mobility Score 5) or modified independence (FIM Mobility Score 6; use an assistive device)
  • Adequate language and cognitive function to participate in routine mobility physical therapy

Exclusion

  • Cardiac history of unstable angina, recent (\<3 mos.) myocardial infarction, congestive heart failure, significant valvular dysfunction
  • Hypertension contraindicating rehabilitation (\>160/100, two assessments)
  • Peripheral arterial occlusive disease (Fontaine II)
  • Orthopedic/chronic pain conditions precluding robot use
  • Pulmonary or renal failure or active cancer
  • Non-stroke neuromuscular or neurological conditions that restrict gait or could confound interpretation of key outcomes
  • Aphasia, unable to follow 2 step commands, or communicate pain, discomfort, or sufficiently interact with PT/staff to participate in PT or PTR treatment assignments, as per judgment of a credentialed clinician
  • Cognitive dysfunction that confounds participation, including diagnosis of dementia including Alzheimer's Disease and Alzheimer's Related Disorders, or active delirium (as defined by Diagnostic and Statistical Manual of Mental Disorders (DSM- 5));
  • Modified Ashworth Spasticity \>3 (considerable increase in muscle tone, passive movement difficult) or contractures that preclude adequate volitional range of motion (ROM) for motor learning
  • Foot and lower leg pain or deformities that complicate safe and effective robot fit
  • Active deep venous thrombosis
  • Skin lesions, infections, other cutaneous or musculoskeletal conditions of the shank that would complicate robot attachment to the leg
  • Untreated and active major depression

Key Trial Info

Start Date :

April 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2020

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04137809

Start Date

April 1 2020

End Date

August 1 2020

Last Update

September 11 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UM Rehabilitation & Orthopaedic Institute

Baltimore, Maryland, United States, 21207